Hematopoietic Stem Cell TransplantationTransplantation, HomologousBone MarrowTransplantation ConditioningBone Marrow TransplantationBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousHematologic NeoplasmsMyeloid CellsMyeloablative AgonistsStem Cell TransplantationWhole-Body IrradiationUnrelated DonorsTransplantation ChimeraHematopoietic Stem CellsBone and BonesTissue DonorsPeripheral Blood Stem Cell TransplantationHistocompatibility TestingHistocompatibilityLiver TransplantationTreatment OutcomeGraft SurvivalCord Blood Stem Cell TransplantationLeukemiaLeukemia, Myeloid, AcuteVidarabineBusulfanRetrospective StudiesGraft vs Tumor EffectHematopoiesisRecurrenceImmunosuppressive AgentsSiblingsChimerismSurvival AnalysisMyelodysplastic SyndromesKidney TransplantationHLA AntigensRemission InductionGraft vs Leukemia EffectCell TransplantationTime FactorsGraft RejectionSurvival RateDonor SelectionBone Marrow DiseasesDisease-Free SurvivalHematologic DiseasesMice, Inbred C57BLMultiple MyelomaCell DifferentiationTransplantation ImmunologyBone RemodelingAnemia, AplasticPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationCombined Modality TherapyTransplantationBone Marrow NeoplasmsAcute DiseaseAntigens, CD34T-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHeart TransplantationFollow-Up StudiesImmunosuppressionCyclosporineFlow CytometryCyclophosphamideDirected Tissue DonationLymphoma, Non-HodgkinLeukemia, MyeloidMycophenolic AcidSurvivorsLung TransplantationBone Marrow PurgingCells, CulturedLymphocyte TransfusionColony-Forming Units AssayLiving DonorsBone DensityAntilymphocyte SerumHepatic Veno-Occlusive DiseaseMinor Histocompatibility AntigensAllograftsMesenchymal Stem Cell TransplantationHematopoietic Stem Cell MobilizationRisk FactorsCytomegalovirus InfectionsLymphocyte DepletionMucopolysaccharidosis IGranulocytesBone ResorptionOrgan TransplantationTransplantation, IsogeneicHematopoietic SystemFetal BloodAntigens, CD